Cargando…
Centhaquine Restores Renal Blood Flow and Protects Tissue Damage After Hemorrhagic Shock and Renal Ischemia
Background: Centhaquine (CQ) (Lyfaquin(®)) is in late stage clinical development as a safe and effective first-in-class resuscitative agent for hemorrhagic shock patients (NCT02408731, NCT04056065, and NCT04045327). Acute kidney injury (AKI) is known to be associated with hemorrhagic shock. Hence, e...
Autores principales: | Ranjan, Amaresh K., Zhang, Zhong, Briyal, Seema, Gulati, Anil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126696/ https://www.ncbi.nlm.nih.gov/pubmed/34012389 http://dx.doi.org/10.3389/fphar.2021.616253 |
Ejemplares similares
-
Sovateltide (IRL-1620) activates neuronal differentiation and prevents mitochondrial dysfunction in adult mammalian brains following stroke
por: Ranjan, Amaresh K., et al.
Publicado: (2020) -
Anti-apoptotic activity of ET(B) receptor agonist, IRL-1620, protects neural cells in rats with cerebral ischemia
por: Briyal, Seema, et al.
Publicado: (2019) -
Resuscitative Effect of Centhaquine (Lyfaquin(®)) in Hypovolemic Shock Patients: A Randomized, Multicentric, Controlled Trial
por: Gulati, Anil, et al.
Publicado: (2021) -
Author Correction: Anti-apoptotic activity of ET(B) receptor agonist, IRL-1620, protects neural cells in rats with cerebral ischemia
por: Briyal, Seema, et al.
Publicado: (2020) -
Controls of Central and Peripheral Blood Pressure and Hemorrhagic/Hypovolemic Shock
por: Ranjan, Amaresh K., et al.
Publicado: (2023)